S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation

被引:159
作者
Liu, Shuangqing [1 ,2 ,3 ]
Zhang, Huilei [1 ,2 ]
Li, Yanan [1 ]
Zhang, Yana [3 ]
Bian, Yangyang [3 ]
Zeng, Yanqiong [4 ]
Yao, Xiaohan [3 ]
Wan, Jiajia [3 ]
Chen, Xu [1 ,2 ]
Li, Jianru [1 ,2 ]
Wang, Zhaoqing [1 ,2 ]
Qin, Zhihai [1 ,2 ,3 ,4 ]
机构
[1] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing, Peoples R China
[2] Univ Chinese Acad Sci, Beijing, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Med Res Ctr, Zhengzhou, Peoples R China
[4] Southwest Med Univ, Sch Basic Med, Luzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
TUMOR PROGRESSION; ALTERNATIVE ACTIVATION; EXPRESSION; METASTASIS; METABOLISM; MICROENVIRONMENT; CONTRIBUTES; SURVIVAL; PROTEIN; CELLS;
D O I
10.1136/jitc-2021-002548
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The peroxisome proliferator-activated receptor gamma (PPAR-gamma)-dependent upregulation of fatty acid oxidation (FAO) mediates protumor (also known as M2-like) polarization of tumor-associated macrophages (TAMs). However, upstream factors determining PPAR-gamma upregulation in TAM protumor polarization are not fully identified. S100A4 plays crucial roles in promotion of cancer malignancy and mitochondrial metabolism. The fact that macrophage-derived S100A4 is major source of extracellular S100A4 suggests that macrophages contain a high abundance of intracellular S100A4. However, whether intracellular S100A4 in macrophages also contributes to cancer malignancy by enabling TAMs to acquire M2-like protumor activity remains unknown. Methods Growth of tumor cells was evaluated in murine tumor models. TAMs were isolated from the tumor grafts in whole-body S100A4-knockout (KO), macrophage-specific S100A4-KO and transgenic S100A4(WT-EGFP) mice (expressing enhanced green fluorescent protein (EGFP) under the control of the S100A4 promoter). In vitro induction of macrophage M2 polarization was conducted by interleukin 4 (IL-4) stimulation. RNA-sequencing, real-time quantitative PCR, flow cytometry, western blotting, immunofluorescence staining and mass spectrometry were used to determine macrophage phenotype. Exogenous and endogenous FAO, FA uptake and measurement of lipid content were used to analyze macrophage metabolism. Results TAMs contain two subsets based on whether they express S100A4 or not and that S100A4(+) subsets display protumor phenotypes. S100A4 can be induced by IL-4, an M2 activator of macrophage polarization. Mechanistically, S100A4 controls the upregulation of PPAR-gamma, a transcription factor required for FAO induction during TAM protumor polarization. In S100A4(+) TAMs, PPAR-gamma mainly upregulates CD36, a FA transporter, to enhance FA absorption as well as FAO. In contrast, S100A4-deficient TAMs exhibited decreased protumor activity because of failure in PPAR-gamma upregulation-dependent FAO induction. Conclusions We find that macrophagic S100A4 enhances protumor macrophage polarization as a determinant of PPAR-gamma-dependent FAO induction. Accordingly, our findings provide an insight into the general mechanisms of TAM polarization toward protumor phenotypes. Therefore, our results strongly suggest that targeting macrophagic S100A4 may be a potential strategy to prevent TAMs from re-differentiation toward a protumor phenotype.
引用
收藏
页数:14
相关论文
共 50 条
[1]   Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy [J].
Bader, Jackie E. ;
Voss, Kelsey ;
Rathmell, Jeffrey C. .
MOLECULAR CELL, 2020, 78 (06) :1019-1033
[2]   On the role of STAT1 and STAT6 ADP-ribosylation in the regulation of macrophage activation [J].
Begitt, Andreas ;
Cavey, James ;
Droescher, Mathias ;
Vinkemeier, Uwe .
NATURE COMMUNICATIONS, 2018, 9
[3]   Expression of S100A4 by, a variety of cell types present in the tumor microenvironment of human breast cancer [J].
Cabezon, Teresa ;
Celis, Julio E. ;
Skibshoj, Inge ;
Klingelhofer, Jorg ;
Grigorian, Mariam ;
Gromov, Pavel ;
Rank, Fritz ;
Myklebust, June Helen ;
Maelandsmo, Gunhild M. ;
Lukanidin, Eugene ;
Ambartsumian, Noona .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (07) :1433-1444
[4]   Targeting macrophages: therapeutic approaches in cancer [J].
Cassetta, Luca ;
Pollard, Jeffrey W. .
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) :887-904
[5]   Control of Macrophage Activation and Function by PPARs [J].
Chawla, Ajay .
CIRCULATION RESEARCH, 2010, 106 (10) :1559-1569
[6]   Tie2 Expression on Macrophages Is Required for Blood Vessel Reconstruction and Tumor Relapse after Chemotherapy [J].
Chen, Lin ;
Li, Jie ;
Wang, Fei ;
Dai, Chengliang ;
Wu, Fan ;
Liu, Xiaoman ;
Li, Taotao ;
Glauben, Rainer ;
Zhang, Yi ;
Nie, Guangjun ;
He, Yulong ;
Qin, Zhihai .
CANCER RESEARCH, 2016, 76 (23) :6828-6838
[7]   S100A4 promotes liver fibrosis via activation of hepatic stellate cells [J].
Chen, Lin ;
Li, Jie ;
Zhang, Jinhua ;
Dai, Chengliang ;
Liu, Xiaoman ;
Wang, Jun ;
Gao, Zhitao ;
Guo, Hongyan ;
Wang, Rui ;
Lu, Shichun ;
Wang, Fusheng ;
Zhang, Henghui ;
Chen, Hongsong ;
Fan, Xiaolong ;
Wang, Shengdian ;
Qin, Zhihai .
JOURNAL OF HEPATOLOGY, 2015, 62 (01) :156-164
[8]   Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer [J].
Davies, BR ;
O'Donnell, M ;
Durkan, GC ;
Rudland, PS ;
Barraclough, R ;
Neal, DE ;
Mellon, JK .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :292-299
[9]   Macrophage Regulation of Tumor Responses to Anticancer Therapies [J].
De Palma, Michele ;
Lewis, Claire E. .
CANCER CELL, 2013, 23 (03) :277-286
[10]   Macrophages as regulators of tumour immunity and immunotherapy [J].
DeNardo, David G. ;
Ruffell, Brian .
NATURE REVIEWS IMMUNOLOGY, 2019, 19 (06) :369-382